EPA (Environmental Protection Agency)
3 records
epa_echo
1 records
fda
4 records
FDA Drug Recall: Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx O
2017-11-22
Class III — Labeling: Incorrect or Missing Package Insert.
View Source
FDA Drug Recall: Lumizyme (alglucosidase alpha), 50 mg/vial, For Intravenous Infusion Only, Rx On
2016-04-06
Class III — Labeling: Incorrect or Missing Lot and/or Exp Date
View Source
FDA Drug Recall: Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For i
2016-03-09
Class II — Presence of Particulate Matter: Glass particles found in the product after reconstitution.
View Source
FDA Drug Recall: Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For i
2016-03-09
Class II — Presence of Particulate Matter: Glass particles found in the product after reconstitution.
View Source
fda_adverse
1 records
FDA AE Manufacturer: Genzyme Corporation
Drug adverse event reporter — Product: CEREZYME
View Source
ftc_enforcement
2 records
Genzyme Corporation and Ilex Oncology, Inc., In the Matter of
2005-02-04
FTC live enforcement action FY2005; matched respondent 'Genzyme Corporation'
View Source
Genzyme Corporation / ILEX Oncology, Inc.
2004-12-20
FTC merger enforcement action FY2005 matter 410083; matched respondent 'Genzyme Corporation'
View Source
lobbying
1 records
nppes
1 records
ny_corps
1 records
NY Corp: GENZYME CORPORATION
1996-12-03
FOREIGN BUSINESS CORPORATION | County: Westchester | Jurisdiction: Massachusetts
View Source
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.